Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Positive and negative outcome analyses We then performed positive outcome analyses, and found markedly increased rates of nausea after GLP-1 RAs treatment (aHR: 1.47, 95% CI 1.33-1.62) as a reported complication
Prime Therapeutics, GLP-1 Therapy to Treat Obesity Among Members Without Diabetes: Three-Year Persistence, 2024
Complete care
The company advises against GLP-1 use during pregnancy, while trying to conceive, or while breastfeeding, and recommends discussing timing and contraception with the prescriber
JAMA, 327(6), 534
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
